Head To Head Top Stocks: Jazz Pharmaceuticals plc (NASDAQ:JAZZ), Valley National Bancorp (NYSE:VLY)

u.s stocks

Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) closed at $151.59 on the last trading session with an decrease of -0.75%, whereas, it previously closed at $152.74. The company has a market capitalization of $8.51 Billion. The company traded shares of 519084 on the trading day while its three month average volume stands at 515.81 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) produced diluted EPS of 10.45. The EPS estimate for next year as estimated by analysts is at 17.21 while EPS for next quarter is estimated at 4.07. Earnings per Share growth for this year is reported at 34.6, while the analysts estimated the EPS growth for next year at 17.21% and Earnings growth for next 5 years stands at 11.05% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 15.8%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is at 14.51 while the forward p/e is at 8.81. The P/S or Price to Sales ratio of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands at 4.14 and Price to Book or P/B for the most recent quarter stands at 2.81. The Price to Free Cash Flow ratio or P/FCF is reported at 9.73. The quick ratio and the current ratio of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) are reported at 3.7 and 3.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands at 11.3, 21.1 and 12.2 respectively

The trailing twelve month Revenue of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is reported at 2.06 Billion with income of 608.8 Million. The outstanding shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) are 56.15 Million. The institutional Ownership of the shares of 94.8 stands at 0.80%, this figure is decreased -0.28 in the last six months. The insider ownership for the shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is ticked at 2.8%, the figure is plummeted -2.22% in the last six months.

Some other important financial aspects to be discussed here for Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is the Mean Target Price estimated by the analysts which stands at 175.76. The 52 week high of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is placed at 154.24 and 52 week low is standing at 116.52.

Performance wise the shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) rose up 4.12% for the week, it also rise 1.87% for the monthly performance, while for the quarter it went down 26.57%. The shares increase 9.67% for the half year and flew up for the Year-To-Date performance. The shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) grew 18.27% for the yearly performance.

Valley National Bancorp (NYSE:VLY)

Valley National Bancorp (NYSE:VLY) closed at $11.45 on the last trading session with an increase of 2.46%, whereas, it previously closed at $11.18. The company has a market capitalization of $4.68 Billion. The company traded shares of 1.92 Million on the trading day while its three month average volume stands at 2.32 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Valley National Bancorp (NYSE:VLY) produced diluted EPS of 1. The EPS estimate for next year as estimated by analysts is at 0.99 while EPS for next quarter is estimated at 0.23. Earnings per Share growth for this year is reported at 16.9, while the analysts estimated the EPS growth for next year at 0.99% and Earnings growth for next 5 years stands at 5% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 2.3%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Valley National Bancorp (NYSE:VLY) is at 11.42 while the forward p/e is at 11.62. The P/S or Price to Sales ratio of Valley National Bancorp (NYSE:VLY) stands at 3.62 and Price to Book or P/B for the most recent quarter stands at 1.14. The Price to Free Cash Flow ratio or P/FCF is reported at 13.8. The quick ratio and the current ratio of Valley National Bancorp (NYSE:VLY) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Valley National Bancorp (NYSE:VLY) stands at 1, 10.3 and 21.3 respectively

The trailing twelve month Revenue of Valley National Bancorp (NYSE:VLY) is reported at 1.29 Billion with income of 333.8 Million. The outstanding shares of Valley National Bancorp (NYSE:VLY) are 408.22 Million. The institutional Ownership of the shares of 52.8 stands at 0.80%, this figure is increased 1.3 in the last six months. The insider ownership for the shares of Valley National Bancorp (NYSE:VLY) is ticked at 0.7%, the figure is plummeted -0.56% in the last six months.

Some other important financial aspects to be discussed here for Valley National Bancorp (NYSE:VLY) is the Mean Target Price estimated by the analysts which stands at 12.61. The 52 week high of Valley National Bancorp (NYSE:VLY) is placed at 12.14 and 52 week low is standing at 9.28.

Performance wise the shares of Valley National Bancorp (NYSE:VLY) rose up 1.87% for the week, it also fell -1.21% for the monthly performance, while for the quarter it went down 1.64%. The shares increase 7.66% for the half year and flew up for the Year-To-Date performance. The shares of Valley National Bancorp (NYSE:VLY) grew 13.08% for the yearly performance.